NCT07704268 Combined Magnetic Stimulation and Ultrasound for Detrusor Overactivity in SCI
| NCT ID | NCT07704268 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Shengjing Hospital |
| Condition | Spinal Cord Injuries |
| Study Type | INTERVENTIONAL |
| Enrollment | 44 participants |
| Start Date | 2026-07-01 |
| Primary Completion | 2027-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 44 participants in total. It began in 2026-07-01 with a primary completion date of 2027-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical trial aims to investigate whether the combination of high-frequency sacral nerve root magnetic stimulation and bladder-directed ultrasound therapy can effectively improve detrusor overactivity (involuntary bladder contractions) and related voiding dysfunctions in patients with spinal cord injury. The main questions it seeks to answer are: What is the effect of high-frequency sacral nerve root magnetic stimulation on detrusor overactivity and bladder function in patients with spinal cord injury? What is the effect of bladder-directed ultrasound therapy on detrusor overactivity and bladder wall compliance in patients with spinal cord injury? Is the combination of these two treatment modalities superior to magnetic stimulation alone?
Eligibility Criteria
Inclusion Criteria: 1. Diagnosis of spinal cord injury (SCI) above the sacral level according to the International Standards for Neurological Classification of Spinal Cord Injury (revised 2011), confirmed by CT or MRI; 2. Detrusor overactivity confirmed by urodynamic study; 3. No severe urinary system diseases such as tumors, stones, infection, or organic urinary tract obstruction; 4. No severe hepatic/renal insufficiency, pulmonary, or cardiovascular diseases; 5. Aged 18-80 years; 6. Able to understand and comply with the required examinations, rehabilitation assessments, and treatment, and provide written informed consent. Exclusion Criteria: 1. Unstable vital signs or critically ill condition; 2. Severe autonomic dysreflexia; 3. Presence of metallic implants within 10 cm of the magnetic stimulation treatment area; 4. Any other diseases or conditions that may interfere with the study outcomes.
Contact & Investigator
Xue Jiang
PRINCIPAL INVESTIGATOR
Rehabilitation Center of Shengjing Hospital, China Medical University
Frequently Asked Questions
Who can join the NCT07704268 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Spinal Cord Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07704268 currently recruiting?
Yes, NCT07704268 is actively recruiting participants. Contact the research team at jiangxueruby@163.com for enrollment information.
Where is the NCT07704268 trial being conducted?
This trial is being conducted at Shenyang, China.
Who is sponsoring the NCT07704268 clinical trial?
NCT07704268 is sponsored by Shengjing Hospital. The principal investigator is Xue Jiang at Rehabilitation Center of Shengjing Hospital, China Medical University. The trial plans to enroll 44 participants.